Jefferies downgraded Procter & Gamble to Hold from Buy with a price target of $175, down from $182. The analyst sees more scope for downside versus upside for the shares from here. Elasticities are getting softer in the U.S. and input costs are rising, while pricing will fade over the next 12 months, the analyst tells investors in a research note. The firm believes this poses risk to market expectations for accelerated sales growth and margin expansion. As such, it sees better opportunities elsewhere in U.S. staples.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble initiated with a Buy at TD Cowen
- Procter & Gamble price target raised to $181 from $170 at JPMorgan
- Procter & Gamble price target raised to $161 from $157 at Stifel
- Colgate-Palmolive price target raised to $105 from $95 at Stifel
- Procter & Gamble price target raised to $174 from $170 at Barclays
Questions or Comments about the article? Write to editor@tipranks.com